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ABSTRACT 
 
Aim: This study was carried out to detect the ESBL and MBL genes and plasmid profile analysis 
among the clinical isolates of Pseudomonas aeruginosa.  
Methods: For this study, 54 P. aeruginosa isolates were obtained from blood, skin, pus, respiratory, 
eyes, urine and sputum of both paediatric and adult patients from Selayang Hospital, Kuala Lumpur. 
Double Disk Synergy Test (DDST) and E-test were used to detect both ESBL and MBL genes. 
Plasmids were detected using Close and Rodriguez with modification (1982) method. QIAprep Spin Kit 
was also used to extract Plasmid DNA and the method was followed according to manufacturer’s 
instructions.  
Results: Among all the P. aeruginosa isolates, 12.97% were ESBL positive, but none of the isolates 
were found to produce MBLs. Plasmids were detected in ten isolates with the POR of (18.51%). The 
overall sizes of the plasmid DNA ranged from the lowest 1.8 kb to the highest 14 kb. These ten isolates 
appear to harbor one or more plasmids with the maximum of four plasmids. Three isolates possessed 
single sized plasmids (3400bp- 4600bp) while three isolates had four plasmids (1800bp- 5800bp) and 
four isolates had two plasmids (220bp-14000bp).  
Conclusion: This study shows the prevalence of ESBL and MBL genes and also shows the presence 
of plasmids among the clinical isolates of P. aeruginosa.  
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INTRODUCTION 
 
Pseudomnasaeruginosa (P. aeruginosa)has become 
increasingly known as an emerging opportunistic 
pathogen. It is commonly involved in infections of 
immunosuppressed patients. It can also cause 
outbreaks of hospital-acquired infections1. It always 
causes nosocomial infections such as bacteremia, 
urinary tract infections (UTIs), and pneumonia. 
Sometime Pseudomonas infections are complicated 
and can be life threatening2. In developing countries, 
P. aeruginosa was reported to be the most common 
pathogen causing wound infection3. Unfortunately 
P.aeruginosa develops multi-drug resistance to most 
of antibiotics4. The emerging antibiotic resistance is a 
serious global problem which resulted treatment 
failures and increased health care costs. Production 
of beta-lactamase is the most common cause of 
bacterial resistance to beta-lactam antibiotics. The 
problem of metallo-beta-lactamase (MBL) production 
is increasing with increasing production of extended-
spectrum beta-lactamase (ESBL) in hospitals.ESBLs  
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and MBLs production is a significant problem in 
clinical isolates of P. aeruginosa.Both the genes have 
been reported to spread from P. aeruginosa to some 
members of Enterobacteriaceae5. The organisms that 
produce ESBL or MBL are also associated with a 
higher mortality and morbidity6. Plasmids are made of 
circular double stranded DNA molecules.Plasmid 
profile analysis examines the total bacterial plasmid 
content. Plasmid mediated antibiotic resistance is 
common in P. aeruginosaand plasmid plays an 
important role in bacterial multidrug resistance.  
 
MATERIALS AND METHODS 
 
For this study, 54 P. aeruginosa isolates were 
obtained from blood, skin, pus, respiratory, eyes, 
urine and sputum of both paediatric and adult 
patients from Selayang Hospital, Kuala Lumpur.  
Double Disk Synergy Test (DDST) and E-test 
were used to detect both ESBL and MBL genes. In 
DDST,discs of third generation cephalosporins and 
augmentin were kept 30mm apart from center to 
center on inoculated Muller-Hinton Agar (MHA). A 
clear extension of the edge of the inhibition zone of 
cephalosporin towards augmentin disc was 
interpreted as positive. The increase in the zone 
diameter was due to the inhibition of the β lactamase 
by clavulanic acid. The procedure for E-test was 
followed according to the manufacturer's instructions. 
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Plasmids were detected using Close and 
Rodriguez with modification (1982) method7. QIAprep 
Spin Kit was also used to extract Plasmid DNA and 
the method was followed according to manufacturer’s 
instructions. Plasmid DNA were resolved by 
electrophoresis in submerged horizontal agarose slab 
gel (0.7%) in Tris- Acetate buffer (TAE) at pH 8.3. 
Power for electrophoresis was supplied by a power 
pack (Bio-rad). Electrophoresis was carried out at 
room temperature from the cathode (-) to anode (+) 
at a constant voltage. The voltage gradient was 
varied depending on whether the gel was run 
overnight or short period of time. Supercoil DNA 
marker was used to estimate the plasmid size.It was 
used in electrophoresis gel each time along with the 
plasmids as molecular weight marker (Table 1). 
 
RESULTS 
 
Among all the P. aeruginosa isolates, 12.97% were 
ESBL positive, but none of the isolates were found to 
produce MBLs.Plasmids were detected in 10 isolates 
with the POR of (18.51%). The overall sizes of the 
plasmid DNA ranged from the lowest 1.8 kb to the 
highest 14 kb. These 10 isolates appear to harbor 1 
or more plasmids with the maximum of 4 
plasmids.Three isolates possessed single sized 
plasmids (3400bp- 4600bp) while 3 isolates had four 
plasmids (1800bp- 5800bp) and 4 isolates had 2 
plasmids (220bp-14000bp) (Table 2). 
 
 
Table 1:Sizes of Supercoil DNA standard marker used for 
molecular weight estimation of plasmid DNA.(Purchased 
from Promega, USA). 
Plasmid No. Molecular weight 
(kb) 
1 10.0 
2 9.0 
3 8.0 
4 7.0 
5 6.0 
6 5.0 
7 4.0 
8 3.0 
9 2.0 
 
Table 2: Frequency of specific sites from which P. 
aeruginosa was isolated 
pecimen  Number of 
specimens  
% of Total  
Pus  22  40.74  
Urine  11  18.51  
Resp.  9  16.67  
Blood  6  11.12  
Tissue  4  7.41  
Genitalia  2  3.70  
 
Fig. 1: Double Disk Synergy Test showing ESBL positive.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2: Agarose (0.7%) gel electrophoresis of plasmid DNA 
extracted from P. aeruginosa 9 using plasmid isolation 
methods and kits. 
 
Lane 1: Close and Rodrigue modified method, 1982  2: 
QIAprep Spin Kit 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3: Agarose (0.7%) gel electrophoresis of plasmid DNA  
Lane M: Supercoli DNA marker  
1: P. aeruginosa 7 4: P. aeruginosa 27  
2: P. aeruginosa 9 5: P. aeruginosa 19  
3: P. aeruginosa 14 6: P. aeruginosa 21 
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Table 3: The different size plasmids in all P. aeruginosa 
isolates 
Sizes of plasmids DNA(kb) 
14 
5.8 
5 
4.6 
3.4 
2.2 
1.8 
 
Table 4: Plasmid occurrence rate (POR) in P. aeruginosa 
No. of Plasmid DNA  Isolates No. POR% 
0 44 81.48 
1 3 5.55 
2 4 7.41 
3 0 0 
4 3 5.55 
5 0 0 
 
DISCUSSION 
 
The DDST was based on the synergistic effect 
(Figure 1) between clavulanate and ceftazidime as a 
result of the inhibition of ESBLs in the presence of 
clavulanic acid. It is one of the most common and 
confirmation test to detect the presence of ESBL. 
The production of ESBLs confers resistance at 
various levels to expanded spectrumcephalosporins, 
such as cefotaxime and ceftazidime, and to 
aztreonam, but not normally to the cephamycins and 
carbapenems8. 
Among the 54 isolates of P. aeruginosa 12.97% 
of isolates shows the ESBL positive. Studies in Iran 
showed 8.1% ESBL production among P. 
aeruginosaisolates9. The studies conducted by others 
depicted low rates, 3.7%10, 4.2%11, 7.7%12 
respectively, of ESBL production in P. aeruginosa. 
However, some studies showed high rate, 20.3%, 
39.41%8 and 35.85%13 of ESBLs productions from P. 
aeruginosa isolates.  
After screening all the P.aeruginosa isolates, 
none of the isolates was found to produce MBL. We 
did not find any isolates produce MBL. Recent 
studies detected MBL from twelve isolates using 
DDST suggesting the efficacy of this method for the 
phenotypic detection of MBL14. 
A plasmid is a small, circular, independent, self- 
replicating double-stranded DNA molecule that is 
extrachromosomal genetic elements carries only a 
few genes naturally exist in bacterial cells as well as 
in some eukaryotes. It is known that several 
important properties of enteropathogenic bacteria are 
plasmid mediated which can be distinguished from 
one another on the basis of the sizes expressed as 
the number of kilo base pairs (kb) of DNA or mega 
Daltons (Md) and determined by electrophoretic 
migration in agarose gel.  
Scientists have taken advantage of plasmids to 
use them as tools to clone, transfer, and manipulate 
genes but the main problem is its separation from 
chromosomal DNA, since the plasmid usually 
compromise not more than 5% of the total DNA. To 
simplify the isolation of plasmid DNA there are 
several protocols have been developed in recent 
years. When selecting one procedure over another, 
factors such as the size of the plasmid to be isolated, 
the simplicity and reproducibility of the procedure, the 
bacterial genus to be lysed, the DNA yield and the 
subsequent use of plasmid DNA, one should aim for 
as few manipulations as possible. It should be noted 
that for most of these rapid procedures will invariably 
be contaminated to lesser or greater extent with 
chromosomal DNA. The detection of plasmids 
depends on the proper methods15.  
Other than using Close and Rodriguez with 
modification (1982) method7, plasmid isolation kit 
(QIAprep Spin) was also used to extract and purify 
plasmid DNA from the bacterial isolates (Fig. 2). The 
plasmid DNA extraction kit purchased gave more 
purified plasmid without contamination with genomic 
DNA and was able to purify even small size plasmids. 
The kit was found to be consistent, i.e., reproducible 
recovery of all plasmid DNA from P. aeruginosa was 
observed. 
Supercoil DNA marker was used to estimate the 
P. aeruginosa plasmid size and was used as 
molecular weight markers in each gel. Plasmids were 
detected in 10 isolates (Fig. 3) with the POR of 
(18.51%) by using Close and Rodriguez method with 
modification (1982)7 and QIAprep Spin Kit (Table 4). 
This finding is in agreement with Nazmul et al., 
(2007)15 where they detected plasmids in 3(5.56%) of 
the isolates. 
These 10 isolates appear to harbour 1 or more 
plasmids with the maximum of 4 plasmids. Various 
plasmid profiles were observed in the isolates. Three 
isolates were found to carry only one plasmid DNA, 4 
isolates were found to harbor 2 different plasmid DNA 
and 3 isolates were found to harbor 4 different 
plasmid DNA. The overall sizes of the plasmid DNA 
ranged from the lowest 1.8 kb to the highest 14 kb 
(Table 3). Forty four isolates (81%) did not carry any 
plasmids.  
Studies in Nigeria showed the plasmid DNA 
ranged from the lowest 0.662 kb to the highest 0.83 
kb16. In another study, Edward Raja et al., 200917, 
detected P. aeruginosa plasmid of approximately 23 
kb, which is larger plasmid compared to our current 
studies. Similar finding was observed in Zimbabwe 
where the plasmid DNA ranged from the lowest 
1.80kb to the highest 8.88 kb18. Another study by 
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Chikwen du et al., (2011)19 showed plasmids ranging 
in size from 794-11845bp in more than 50% of all the 
tested isolates.  
Studies have shown the involvement of plasmid 
in multidrug resistance. Therefore, plasmids found in 
our studies may play an important role in ESBL 
productions and multidrug resistance. The different 
sized plasmids found in our studies might be involved 
in multidrug resistance. Further studies on each 
plasmids are necessary to confirm the association of 
these plasmids in multidrug resistance.  
 
CONCLUSION 
 
This study shows the prevalence of ESBL and MBL 
genes and also shows the presence of plasmids 
among the clinical isolates ofP. aeruginosa. These 
plasmids may possess multidrug resistant genes and 
also may be related to the production of ESBL genes 
but needs further study to confirm this. 
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